Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Invested Capital (2016 - 2025)

Immucell's Return on Invested Capital history spans 15 years, with the latest figure at 0.01% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 1.0%, while the annual FY2025 figure was 0.01%, 1.0% up from the prior year.
  • Return on Invested Capital reached 0.01% in Q4 2025 per ICCC's latest filing, down from 0.09% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.09% in Q3 2025 to a low of 0.2% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 0.02%, with a median of 0.01% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: dropped -21bps in 2023, then increased 28bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2021, then tumbled by -919bps to 0.07% in 2022, then skyrocketed by 91bps to 0.01% in 2023, then tumbled by -129bps to 0.01% in 2024, then soared by 61bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Return on Invested Capital are 0.01% (Q4 2025), 0.09% (Q3 2025), and 0.08% (Q2 2025).